Anaptysbio (ANAB) Change in Acquisitions & Divestments (2017 - 2026)

Anaptysbio has reported Change in Acquisitions & Divestments for 10 years, with the latest figure at $35.0 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Acquisitions & Divestments fell 74.53% year-over-year to $35.0 million; the trailing twelve-month figure through Mar 2026 stood at $322.1 million (down 33.71% YoY), and the FY2025 full-year result was $424.5 million, down 10.84% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $35.0 million, down from $73.5 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $149.2 million in Q4 2022, with the low at $9.6 million in Q1 2022.
• Historically, Change in Acquisitions & Divestments has averaged $105.5 million across 5 years, with a median of $110.0 million in 2024.
• Annual changes were most pronounced in 2022 — Change in Acquisitions & Divestments plunged 84.8% — and 2023, when it surged 1294.24%.
• Anaptysbio's Change in Acquisitions & Divestments stood at $149.2 million in 2022, then decreased by 22.44% to $115.8 million in 2023, then dropped by 20.75% to $91.7 million in 2024, then fell by 19.89% to $73.5 million in 2025, then plunged by 52.38% to $35.0 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $35.0 million (Q1 2026), $73.5 million (Q4 2025), and $123.0 million (Q3 2025), per Business Quant data.